The University of Calgary is a public research university located in Calgary, Alberta, Canada. The University of Calgary started in 1944 as the Calgary branch of the University of Alberta, founded in 1908, prior to being instituted into a separate, autonomous university in 1966.

During the past decade, University of Calgary Health - The Gastrointestinal Research Group (GIRG) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Calgary Health - The Gastrointestinal Research Group (GIRG)" are "Crohn Disease" (3 trials). Many other conditions were trialed in "University of Calgary Health - The Gastrointestinal Research Group (GIRG)" in a lesser frequency.

Most popular intervention types in "University of Calgary Health - The Gastrointestinal Research Group (GIRG)" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Calgary Health - The Gastrointestinal Research Group (GIRG)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "University of Calgary Health - The Gastrointestinal Research Group (GIRG)". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University of Calgary Health - The Gastrointestinal Research Group (GIRG), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Calgary Health - The Gastrointestinal Research Group (GIRG), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".